Viking Therapeutics, Second Sight Medical Products, Ekso Bionics Holdings, Ohr Pharmaceutical and Cardiome Pharma topped last week’s NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
In case you missed it, here is this week’s big news roundup in Life Science.
In case you missed it, here is this week’s big news roundup.
Silver Viper Minerals Corp. (the “Company” or “Silver Viper”) (TSX-V: VIPR) is pleased to announce that Alex Peter Tsakumis has been appointed by the Company as Vice President of Corporate Development.
By Pia Rivera
Berkwood Resources Ltd. (TSXV:BKR, FSE:BK2, WKN:A110N3) (“Berkwood” or the “Company”) is pleased to announce that it has completed the first hole of the Phase 2 drill program on Berkwood’s Zone 1 Graphite Body.
By Micha Boon
Margaux Resources Ltd. (TSXV:MRL) (OTCQB: MARFF) (“Margaux” or the “Company”) is pleased to announce that further to its press release dated November 2, 2017 and subject to receiving final regulatory approvals, it has closed the first tranche of its previously announced non-brokered private placement (the “Offering”) by issuing:
4,399,999 units (“Units”)
CRISPR Therapeutics announced the submission of a clinical trial application for CTX001 in β-thalassemia.
Pieris Pharmaceuticals announced it received approval from the Human Research Ethics Committee and authority from the Therapeutic Goods Administration to start an in-human study for PRS-060/AZD1402 in Australia.
Heat Biologics received written responses from the FDA following its Type C meeting regarding its planned registrational HS-110 clinical trial design for the treatment of non-small cell lung cancer.
By Melissa Shaw
Silver Spruce Resources (TSX VENTURE:SSE)(FRANKFURT:S6Q) (“Silver Spruce” or the “Company”) is pleased to announce that it has received its first assays of mineralized rock samples taken from the development/production dumps at the Kay Mine in Arizona.
These first twenty-five samples were taken for data verification purposes to confirm the tenor of
By Pia Rivera
Noram Ventures Inc. (TSX-V: NRM Frankfurt: N7R OTCBB: NRVTF) (“Noram” or the “Company”) is pleased to announce that further to its news release on (November 23) it has enganged Gonzalo Javier Montebelli as Exploration Geologist and will supervise the surface and sub-surface sampling on its 2,709 hectares Arizaro East mineral
Fundamental Research Corp (FRC) has initiated coverage on Asante Gold Corporation (CSE:ASE), with a BUY rating and a fair value estimate of C$0.63 per share.
GT Biopharma announced it started the proof of concept phase 1 clinical trial with GTP-004 against rare muscular disease myasthenia gravis.
By Melissa Shaw
Bannerman Resources (ASX:BMN) (NSX:BMN) (“Bannerman” or the “Company”) is pleased to announce that the Etango Membrane Study has successfully progressed through the initial test work phase at the Etango Heap Leach Demonstration Plant, validating the potential for further capital and operating cost reductions, to be confirmed in the DFS Update.